个性化文献订阅>期刊> Expert Opinion on Therapeutic Targets
 

Targeting fibroblast-growth-factor-receptor-dependent signaling for cancer therapy

  作者 Heinzle, C; Sutterluty, H; Grusch, M; Grasl-Kraupp, B; Berger, W; Marian, B  
  选自 期刊  Expert Opinion on Therapeutic Targets;  卷期  2011年15-7;  页码  829-846  
  关联知识点  
 

[摘要]Areas covered : Information from these sources as well as ongoing work from the authors' groups is used to outline the physiological functions of FGF signaling and to highlight how the high oncogenic effects of deregulated FGFs and FGFRs derive from their physiological functions. The biological effect of deregulated FGFR signaling in malignant diseases is described and the current state of therapeutic targeting of FGFR is summarized. Expert opinion : Strategies for targeting FGFR-signaling for cancer therapy are very promising, but need to be carefully developed based on the physiological roles of FGF signaling. Preventive measures may be necessary for protection from FGF-related side effects. Combined targeting of several receptor tyrosine kinases or combination with other therapies may be a useful way of avoiding or ameliorating side effects. FGF-related markers of prognosis and therapy response still need to be investigated.

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内